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1. ABBREVIATIONS  
AD  Alzheimer’s Disease 
ANOVA Analysis Of Variance 
ATP  Adenosine triphosphate 
BBB  Blood Brain Barrier 
CNS   Central Nervous System 
DAMPs Damage Associated Molecular Patterns 
ETS  Electron Transport System 
HI  Hypoxic-ischemic 
IBD  Inflammatory Bowel Disease 
LAM  Lipoarabinomannan 
LPS  Lipopolysaccharide 
LTA   Lipoteichoic acid 
MS  Multiple Sclerosis 
NF-κB  nuclear factor kappa-light-chain-enhancer of activated B-Cells 
OXPHOS Oxidative phosphorylation  
PAMPs  Pathogen associated molecular patterns 
PNS  Peripheral Nervous System 
PRRs   Pathogen recognition receptors 
RA  Rheumatoid Arthritis 
SEM  Standard Error of the Mean 
TLRs   Toll Like Receptors 
 
 
 
 
 
 
 
 
 
 
4	
2. ABSTRACT 
Introduction: Toll Like Receptors (TLR) are pathogen recognition receptors (PRRs), 
which play major roles in recognition and provoking inflammatory responses upon 
activation by pathogens such as bacteria, viruses and fungi. TLR2 is activated by 
binding to Pathogen associated molecular patterns (PAMPs) such as Lipoteichoic acid 
(LTA) and Lipoarabinomannan (LAM), which are found in Gram-positive bacteria 
respective Mycoplasma. As well as infections, Hypoxic-Ischemic (HI) events are a 
known risk factors for developing neonatal brain injury. Neonatal brain injury can 
result in conditions like Cerebral palsy, learning difficulties and even death.  
Aim of the study: The pathology behind neonatal brain injury is still not fully 
understood. By studying some specific cellular mechanisms such as cellular 
respiration, myelinisation, development of neurons and microglia in a Toll like 
receptor dependent manner, we could contribute to the understanding of this complex 
issue.     
Methods: TLR2 -/-  mice and TLR2+/+ mice were injected intraperitoneally (ip.) with a 
TLR2 ligand (P3C) or saline 14h before exposed to Hypoxia-Ischemia (HI). The HI 
procedure were executed by ligating one of the common carotid arteries followed by 
putting the pups in an Oxygen deficient chamber for 50min. Brains were collected 
and stained immunohistochemically using different antibodies for neurons (MAP2), 
myelinisation (MBP) and Microglia (Iba1). Evaluation of the cellular respiration were 
made by using a high-resolution respirometer.      
Results: Here we present data to show that systemic activation of TLR2, with a 
synthetic ligand, increases subsequent HI brain injury in neonatal mice as 
demonstrated by increased neural tissue loss as well as reduced myelination. Using 
high-resolution respirometry, we show that systemic activation of TLR2 suppresses 
respiration in brain-isolated mitochondria. 
Conclusion: The results suggest that infection and inflammation might exacerbate 
hypoxic-ischemic injury through mitochondrial energy failure.    
 
Key words: inflammation, Toll like receptor 2, neuroinflammation, mitochondrial 
respiration, neonatal brain injury, cerebral palsy 
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3. BACKGROUND 
 
3.1 Inflammation 
The word inflammation originates from the Latin word Inflammare, which means “to 
set on fire”.  The basic symptoms of inflammation; redness, swelling, heat and pain, 
were described already by the ancient Roman encyclopaedists, by the name Cornelius 
Celsus 1. Rudolf Virchow modified the Celsus description of inflammation by adding 
“loss of function” to one of the cardinal symptoms. Some sources claim that it was 
Galen who added the fifth symptom 2. Galen was the first one to describe 
inflammation as beneficial to the injury response.  Centuries later, inflammation is 
still a hot topic by researchers worldwide, and is much more complex than Celsus 
thought.  
 
Today inflammation is considered to be a non-specific response to any type of bodily 
injury. The five symptoms can nowadays all be explained by basic human physiology 
such as increased blood flow, increased extracellular fluid and release of chemicals 
that stimulate nerve endings3.  
 
Inflammation is present whether it serves as a response to infections by bacteria, 
viruses, fungi’s or prions. It is also present when the body is affected with trauma; 
burns, hypoxia or ionizing radiation just to name a few. For example, it serves a 
pivotal role during many autoimmune diseases such as Type 1 diabetes mellitus 
(T1DM), Inflammatory Bowel Disease (IBD), celiac disease, Rheumatoid arthritis 
(RA)4.   
 
It is nowadays accepted to divide inflammation in “acute” or “chronic” depending on 
the molecular mechanism and immunological response behind these two phenomena.   
 
3.2 Immune cells and Pattern recognition receptors 
 Immune cells, known as leukocytes, involved in the acute response are phagocytic 
cells such as neutrophils and macrophages. Macrophages are innate immune cells that 
differ in morphology and specificity regarding which tissue they reside.  For instance, 
brain macrophages are called microglia and liver macrophages are called Kuppfer 
cells. Macrophages are differentiated monocytes, and like the majority of immune 
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system, products of the Myelopoesis. It is known that microglia differ in 
differentiation in comparison to some other macrophages 41.  
 
Macrophages express a wide range of receptors on the cell surface6. The receptors of 
interest during acute inflammation are called Pattern Recognition Receptors (PRRs). 
PRRs can be divided into subgroups of receptors whether they recognize molecules 
such as Pathogen Associated Molecular Patterns (PAMPs) or Damage Associated 
Molecular Patterns (DAMPs).  The PRRs differ in function whether they are activated 
by invading pathogens coming outside of the body (microbes, viruses), or as a 
response to endogenous molecules released during cell damage or cell death.  The 
Toll Like Receptor family is today the most widely studied group of PPRs.  
 
Activation of macrophage PRRs results in various intracellular pathways that result in 
e.g. leukocyte extravasation, production of various cell derived mediators (e.g. 
cytokines), phagocytosis, vasodilatation and increased permeability and activation of 
the adaptive immune system.  Every step in the activation of the immune system is to 
help eliminate the pathogen/danger.  
 
There are major differences in immune cells and mediators involved, duration, onsets 
and outcomes between acute and chronic inflammation. The immune cell types in 
chronic inflammation are dominated by monocytes, lymphocytes and plasma cells, 
while in acute inflammation the majority of cells involved are macrophages and 
granulocytes.   
 
3.3 Toll Like receptors 
The discovery of TLRs goes back to 1985 when scientist Christiane Nüsslein-Volhard 
analyzed Drosophila (fruit flies), and found a fly with abnormal dorso-ventral 
proportions. This defected Drosophila discovery resulted in excitement among the 
German scientist who reportedly shouted “Das war ja Toll” meaning That was 
amazing. The mutated gene behind this embryonic anomaly was identified, and 
received the iconic name the Toll gene.  A decade later scientists discovered that 
without the Toll gene, the Drosophila would not survive a fungal infection10.   
Nowadays thirteen Toll genes have been identified.  
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Early experiments showed that activation of Toll in Drosophila led to an intracellular 
activation of nuclear factor kappa-light-chain-enhancer of activated B-Cells (NF-κB) 
11 that resulted in various defense mechanisms.  Medzhiov et al identified the first 
TLR in mammals, it is known today as TLR412.  
 
TLRs are a family of receptors that plays a key role in the activation of the innate 
immune system. They recognize different PAMPs depending on which subtype of 
TLR is involved. PAMPs are structures on pathogens primary consisting of lipids, 
proteins, sugar molecules and nitrogen bases, which are highly specific for pathogens 
and does not exist in mammals. Other well-described proficiency of the PAMPs is 
that they are essential for the survival of the pathogen13, 14, which from an 
evolutionary perspective makes mutations in PAMPs unfortunate for the pathogen. 
Sugar Complexed PAMPs (SCPs) are the largest group of PAMPs.   
 
Up to this day, 13 TLRs have been found in mammals TLR1-TLR13, although only 
TLR1-TLR10 has been found in humans. They vary depending on their intracellular 
location, ligands, and adapter molecules and in which cells they are found.  
 
TLRs can be separated in subgroups whether they are found on the cell surface or in 
intracellular vesicles. TLR1, TLR2, TLR4, TLR5, TLR6 and TLR11 are all expressed 
on the surface of the cell. Except their similarities in location they also mainly 
recognize microbial lipids, proteins and lipoproteins found in the cell membrane.   
TLR3, TLR7, TLR8, TLR9 are found mainly in intracellular vesicles and recognizes 
microbial nucleic acids.   
 
3.4 TLR 2 
It is known that TLR2 is involved in recognition of a wide range of PAMPs (found in 
bacteria, fungi, viruses and parasites) 15.  Specifically including lipopeptides from 
bacteria, lipoteichoic acid from Gram- positive bacteria, and lipoarbinonnan from 
Mycobacteria. Upon activation TLR2 forms heterodimers with TLR1 or TLR616.  
Next step in the cascade reaction after the dimerization is recruitment of adapter 
molecules. MyD88, Tirap (even known as Mal), Trif and Tram are all adapter 
molecules known to be involved in TLR signaling process23. For TLR2 the adapter 
protein is MyD88.  This results in activation of NFκ-B, which is a protein complex 
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that enters the cell nucleus and controls transcription of DNA22. Resulting in 
transcription of inflammatory cytokines such as Tumor Necrosis Factor-alpha (TNF-
α) together with a wide range of interleukins (IL-1α/β, IL-6, IL-8) 24. TLR2 are found 
in microglia, Schwann cells, macrophages, monocytes, dendritic cells, B-cells and T 
cells just to name a few. 
 
3.5 Cellular respiration 
The cellular respiration which results in ATP production is a well conserved series of 
metabolic reactions that can be found in both prokaryotes and eukaryotes. In short, the 
cellular respiration is process where nutrients like sugar, amino acids and fatty acids 
combined with the presence of oxygen results in ATP production. The respiration 
consists of four well described steps 43,44. It starts with glycolysis, followed up by the 
citric acid cycle (even known as the Krebs cycle) and ends with the electron transport 
chain and oxidative phosphorylation (in some literature the last two steps are 
considered as one step). The different steps occur in two different intracellular 
locations, the cell cytoplasm and the mitochondria.  The glycolysis is the only step of 
the respiration that can occur without oxygen and independent of mitochondria. All 
other steps, in most eukaryotes, include different parts of the mitochondria.  
 
Throughout the last two steps of the cellular respiration electrons are transferred from 
electron donors to electron acceptors. Oxygen serves as an electron acceptor.  This 
redox reaction produces energy that is used to form ATP. ATP synthase, which is 
found in the mitochondrial inner membrane is an enzyme that binds together ADP + 
Pi to form ATP. This unique enzyme consists of two subunits called F0 and F1, where 
the F0 subunit is embedded in the inner membrane of the mitochondria and the F1 in 
the mitochondrial matrix. The F0 subunit rotates as protons (H+), supplied from the 
electron transport chain, passes through the ATP synthase catalyzing the ATP 
reaction45.  
 
3.6 Neuroinflammation 
Neuroinflammation is inflammation of the nervous tissues. Inflammation in the 
Central Nervous System (CNS) has been of interest among researchers for some time 
already. Inflammation in the Peripheral Nervous System (PNS) is also a hot topic in 
modern medicine, but unfortunately not in this study. CNS inflammation occurs as a 
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response to different crises such as bacterial infections, traumatic injury of the brain, 
neurodegenerative disorders, autoimmune diseases and stroke25.  Inflammation in the 
brain can be acute as well as chronic.  Brain inflammation can be restricted to a local 
region as a result of a focal stroke, or involve major parts of the brain subsequently to 
traumatic injury. Chronic inflammation is present in disorders like Alzheimer’s 
disease (AD), Multiple sclerosis (MS) and Parkinson’s disease26, 27, 28.   Recent reports 
even suggest that inflammation is present in conditions like depression and 
schizophrenia29.  The CNS is considered to be immune privileged site because of 
exclusive defense mechanisms like the Blood Brain Barrier (BBB) and the lack of 
conventional lymphatic drainage system. The BBB is a uniquely designed membrane, 
that separates the brain from the rest of the circulation, with both good and bad 
properties.  
 
For example, a good function is that it protects the brain magnificently well form 
harmful substances which unfortunately leads to another well-known problem in 
targeting the brain with drugs. Today it is quite impossible to get the desired drug and 
dosage to the brain through normal drug administration. This has led to more research 
in drug design and understanding of the BBB. The BBB is a membrane that consists 
of endothelial cells which are supported by astroglia, perivascular macrophages, 
pericytes and a basal lamina5.  The BBB is affected in many pathological conditions 
which leads to permeability changes in the BBB. Easier passage of cells, molecules, 
fluids and proteins can be the reason for the condition or the outcome7. Changes in the 
BBB has been observed in conditions like Bacterial Meningitis, Brain Abcesses, 
Epilepsy, Multiple Sclerosis and Alzeimers8,9.     
 
3.7 Neonatal Brain Injury 
Neonatal brain injury was once believed to depend primarily on events of birth 
asphyxia but is nowadays modified and redefined, by the scientific community, to be 
a much more multifactorial condition. Neonatal brain injury that results in 
encephalopathy, clinically starts with lethargy followed by hyper excitability and ends 
in stupor33,35, affects 1-3/1000 newborns in high-income countries and the incidence 
rate is significantly higher in low-income countries where up to 20/1000 newborns are 
affected32.  Known risk factors for developing neonatal brain injuries are maternal 
infections as well as inflammation, due to HI, and preterm birth36.  Neonatal 
10	
encephalopathy is a serious condition where 15-20 % die during the newborn period, 
and 25% suffers permanent neurological deficits 34, 35. Acute neurological disorders 
after birth like status epilepticus and stroke that results in fatal outcomes is highest in 
the child’s first year30, 35.  It is reported that some forms of neonatal stroke have an 
incidence of 1/4000 live births31.  Different types of learning disabilities, behavioral 
syndromes and cerebral palsy are unfortunate possible outcomes after neonatal 
encephalopathy35. Today, recent reports and understandings, Hypoxic-Ischemic 
Encephalopathy (HIE) is still the most described clinical condition. Underlying 
mechanisms of neonatal brain injuries are still not fully understood and the only 
treatment for HIE today is moderate hypothermia37. However, therapeutic 
hypothermia has limitations and many infants continue to survive with disability, and 
hypothermia is unsafe to use in preterm infants. Thus, there is an urgent need to better 
understand how neonatal brain injury develops and identify new therapeutic targets. 
 
4. AIM OF THE STUDY 
The role of TLR2 in response to infections in general is well determined, but the role 
in neonatal brain injury and the underlying mechanisms has not been fully mapped 
out. Even though perinatal infections usually are caused by pathogens that involves 
TLR2 signaling. To gather knowledge behind the complexity of neonatal brain 
injuries is of great interest for development of possible future treatments.  Here we 
focus on a couple of interesting questions and hypotheses:  The role of TLR2 
activation/suppression prior to HI, how is the cellular respiration affected, how severe 
is the neural loss, how is the myelinisation effected as well as the possible effects on 
Microglia.     
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5. MATERIAL AND METHODS 
 
5.1 Animals 
To study the role of TLR2 in neonatal brain injury we used TLR2 -/- and TLR2 +/+ 
mice. In order to acquire the mice of interest we purchased wild type mice 
(C57BL/6J) that are TLR2+/+ from the Charles River Laboratories (Wilmington, MA, 
USA), and bred them with homozygote TLR2−/− (B6.129-Tlr2tm1Kir/J) mice, which 
were bought from the Jackson Laboratory (Bar Harbor, ME, USA). The C57BL/6J 
mice are a widely used inbred strain and even the first ones to have its genome 
sequenced. From cross-breeding these homozygote mice we obtained generations of 
heterozygote TLR2+/- mice, which were then crossed to give mixed genotypes in each 
litter consisting of heterozygote TLR2+/-, TLR2+/+ and TLR2-/- pups, which were used 
in this study. Mice of both genders were studied. Genotyping was performed 
following the protocol from the Jackson Laboratory (for full protocol please see 
Appendix, AP.1). Heterozygote pups were not analyzed in the study. We used a total 
number of 33 mice for the immunohistochemistry, 13 TLR2 +/+ and 20 TLR2 -/-. And 
for the respiration analysis 13 mice per group.  
 
5.2 Ethics 
Animal experimental procedures conformed to guidelines established by the Swedish 
Board of Agriculture (SJVFS 2015: 38), were approved by the Gothenburg Animal 
Ethics Committee (18–2015), and are reported in a manner consistent with the 
ARRIVE (Animal Research: Reporting in Vivo Experiments) guidelines. 
 
5.3 P3C administration  
We injected postnatal-day 8 (P8) mice with Pam3CSK4 (P3C, Invivogen, France) or 
Saline (0.9% NaCl) 14h before the HI events. P3C was injected intraperitoneally (i.p.) 
with a dosage of 5mg/kg. The P3C dosage was based on previous studies17, 18, 19.  
 
5.4 Hypoxia-Ischemia 
To induce neonatal hypoxic-ischemic injury we used a well-established technique. 
The surgical procedure is as follows, and has been used in previous studies19, 20.  At 
P9 the mice were anesthetized using isoflurane, 3.0 % isoflurane for induction and 
1.0-1.5% for maintenance, in a mixture of Nitrous oxide and oxygen (1:1).  The left 
12	
common carotid artery was exposed and then ligated using non-absorbable prolene 
sutures; the surgical procedure is done with microscope guidance and does not last 
more than five minutes. After the surgical operation, the mice pups were returned to 
their home cage with the dam to recover for 1h.  
 
After the recovery, the mice were placed in an incubator for the hypoxic-ischemic 
insult. Rectal temperature of each mice was measured. The incubator contains a 
humidified gas mixture (36°C) with 10.00 ± 0.01 % oxygen in nitrogen. The mice are 
in the incubator for 50min.  After the hypoxic insult the mice were returned to their 
cage.  
 
The combination of artery ligation and exposure to hypoxia induce cerebral hypoxia-
ischemia in the hemisphere ipsilateral to the artery ligation and thus result in 
unilateral brain damage.  
 
5.5 Immunohistochemistry 
Five days after the insult the mice were killed with an overdose of thiopental. Five 
days have been shown in previous studies to be enough time to establish an adequate 
injury19. The mice were perfused with saline and 5% buffered paraformaldehyde 
(Histofix;Histolab, Sweden). The brains were quickly removed and further fixed in 
formaldehyde 4 oC overnight. Dehydration was done with graded series of ethanol 
and X-tra solv (Medite), and then the brains were embedded in paraffin. Ten µm thick 
coronal sections were cut at five levels at 40 sections apart (Fig 1.) for 
immunohistochemical staining. Antigen retrieval was achieved by boiling gently the 
sections in 10 mM sodium citrate buffer (pH 6.0) for 10min. Then placed in H2O2 
(3% in PBS) for 10min. For blocking unspecific binding activity, the sections were 
immersed in a blocking solution (4% horse serum, 3% bovine serum albumin in 
phosphate-buffered saline, PBS) for 30min. Then the sections were incubated with the 
primary antibodies at 4 oC overnight: mouse monoclonal anti microtubule-associated 
protein 2 (MAP-2; clone HM-2, 1:1000; Sigma-Aldrich) or mouse monoclonal anti 
myelin basic protein (MBP, 1:10,000, SMI-94R; Covance) or polyclonal rabbit anti 
ionized calcium binding adaptor molecule 1 (IBA1, Wako).  For the secondary 
antibody we used corresponding biotinylated antibodies (Vector Laboratories). The 
sections were coated with the secondary antibodies for 1h in room temperature (RT).  
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This was followed by treatment of sections by the Vectastain ABC Elite kit (Vector) 
as outlined by the manufacturer.  To visualize the target proteins (MAP2/MBP) 
enzyme substrate DAB was used.  
(For full staining protocol please see the appendix, AP.2).   
 
  
5.6 Assessment of brain injury 
A Nikon Optiphot-2 microscope equipped with AVT dolphin F145B camera (Allied 
Vision Technologies) was used for capturing images. Positively stained areas were 
measured using Olympus Micro Image analysis software system (V4.0, Olympus 
Optical). The MAP-2 stained area in the ipsilateral hemisphere was subtracted from 
the contralateral hemisphere and the result was divided by MAP-2 area in 
contralateral hemisphere to obtain % MAP-2 loss. MBP stained area was measured in 
subcortical region and the % loss was calculated as for MAP-2. One section at each 
brain level was analyzed. Data were analyzed by two-way analysis of variance 
(ANOVA) followed by Bonferroni post hoc test when analyzing brain injury at 
different levels, and by two-tailed unpaired t-test when comparing total brain injury. 
Graphpad Prism V 6.01 was used for data analysis, and data are presented as 
Mean ± SEM.  
 
5.7 Microglia Stereology 
A Leica DM 6000 B Microsystem microscope integrated with MBF Bioscience 
Neurolucida and Stereoinvestigator 64 software was used for the Stereology analysis. 
The third coronal section level (L3) of the Iba-1 stained sections was used for the 
analysis. Areas from each hemisphere, the contralateral and the injured ipsilateral, on 
each brain were mapped out using the Freehand tool at a 5x zoom. Microglia cell 
counting was performed using the Fractionator Probe with a grid size of 1000 µm x 
1000 µm. Approximately 20 grids from each hemisphere were counted. The estimated 
cell population from each hemisphere was divided by the area of the hemisphere. The 
cell counting was carried out by a person blind to the samples.  An unpaired t-test was 
performed to analyze the data. (For full Stereology protocol please see appendix, AP. 
3).  
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5.8 Mitochondrial isolation 
To isolate the mitochondria in the brain we used a method described in detail in a 
previous study21.  Briefly, one hemisphere from P9 mice was removed and then 
homogenized using a 2-mL all-glass Dounce tissue grinder (Kontes Glass Co., 
Vineland, NJ, USA) in 1.9mL isolation buffer (IB) and then centrifuged at 1100 g for 
2 min (4 oC). The supernatant was collected and divided into two Eppendorf tubes 
with a final volume of 700 µL each and mixed with 75 µL of 80% Percoll Soltuion 
(GE Healthcare) then carefully layered on the top of freshly made 10% Percoll 
Solution (750 µL, 80% Percoll was diluted in IB to prepare the 10% solution) in a 
2 mL Eppendorf tube and centrifuged at 18 500 g for 10 min (4°C).  
 
The myelin-containing top fraction was removed leaving the mitochondria-enriched 
pellet in the bottom of the Eppendorf tube. One microliter sucrose washing buffer was 
added to the pellet then mixed and finally centrifuged at 10 000 g for 5 min at 4°C. 
The final mitochondrial pellet was resuspended with 1 mL MIR05 buffer and placed 
on ice until the next step, the respiration analysis 55. 
 
 
5.9 Mitochondria respiration analysis 
Mitochondrial respiration was measured using a modified protocol from previous 
studies38, 39, 40, 41. The full protocol has previously been described21. 
Briefly, we used a high-resolution respirometer, model Oroboros Oxygraph-2 k 
(Oroboros Instruments, Innsbruck, Austria). Samples were run in pairs of saline and 
P3C in two chambers of O2K devices. All measurements were performed at 25℃ in 
2.1 mL MIR05 buffer. The O2 flow was monitored in real-time using DatLab V 6.0 
software. After injecting 50 µL of isolated mitochondria into the chambers, saturating 
dosages of substrates were added to obtain final concentration of 4.8, 2.5, 0.12 mM 
for pyruvate, malate, and ADP respectively and 1 µmol/L of carbonyl cyanide 4-
trifluoromethoxy phenylhydrazone (FCCP). Pyruvate and malate initiate leak state 
respiration, ADP induces complex I-mediated oxidative phosphorylation (OXPHOS 
capacity), and FCCP induces uncoupled respiration that corresponds to electron 
transport system (ETS) capacity. Respiratory control ratio (RCR) was calculated by 
dividing OXPHOS capacity by leak state respiration. OXPHOS capacity was 
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corrected for leak state respiration by subtracting leak state value from max OXPHOS 
to obtain Free OXPHOS capacity. Free ETS capacity was also calculated by 
subtracting leak state value from ETS capacity. All obtained values were normalized 
to total protein content, and two-tailed paired t-test was performed to analyze the data. 
 
5.10 Statistics 
As mentioned before, we analyzed the brain injuries (MBP/MAP2) using a two-way 
analysis of variance (ANOVA) followed by Bonferroni post hoc test when comparing 
different levels, and a two-tailed unpaired t-test when comparing total brain injury. 
For the respiration analysis, we used a two-tailed paired t-test. We did not perform 
specific power calculations but used similar numbers of mice as our previous studies 
using the same brain injury model.  
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6. RESULTS 
Here we present the results that systemic activation of TLR2 using P3C, prior to HI 
insults, in neonatal mice exacerbates neural tissue loss as well as affects the 
mitochondrial respiration, seen as MAP-2 and MBP stained area loss respective 
suppression on mitochondrial respiration.  
 
6.1 MAP-2 Stained Neuron loss 
To explore the effect of TLR2 activation on HI injury, P3C or Saline were injected 
14h before the HI insult. To analyze the size of the damage we collected the brains 
five days after the HI insult, i.e. postnatal day 14, and then stained the tissue with 
MAP-2. The MAP-2 protein stabilizes microtubule growth, and it is believed to have 
an important role in adequate neuron development.  Samples from five different 
coronal section levels (L1-L5) of the cerebrum was used (Figure 1 (a) and (b)).  P3C 
administration significantly increased the neural loss in two of the five levels (Figure 
1(a)). The average loss of neural tissue in all five levels increased as well, by 
14.0% ± 2.4 (p < 0.001, Figure 1(e)).  As mentioned above we used pups of both 
gender, no difference in sensitization between the two genders was observed (data not 
shown).  To rule out a possible temperature depended effect on the injury size we 
measured rectal temperatures at the time of HI induction. Prior injection with P3C did 
not affect the temperature (Saline: 35.2 ± 0.2℃; P3C: 35.4 ±0.1℃, n = 8/group, 
p = 0.51). 
 
To answer the question whether P3C exposure is TLR2 dependent, we used TLR2 -/- 
and TLR2 +/+ mice.  In TLR2 +/+ mice (n = 13) the MAP-2 stained neuron loss was 
more extensive than in TLR2-/- (n=20) (Figure 1(b)). And in general, the TLR2-/- mice 
were significantly protected against the injury by 17.1% ± 2.5 (p < 0.001, Figure 1(f)). 
 
6.2 MBP Stained Myelin loss  
To investigate the potential myelin loss caused by TLR2 activation prior to HI, we 
stained three levels (L2-L4) of coronal sections from the cerebrum with MBP. P3C 
caused a 13.2% ± 6.2 overall increase in HI-induced loss of MBP (Figure 1(g)) 
compared to saline injected controls. However, regarding the individual levels of the 
brain no statistically significant difference could be proven (Figure 1(c)).  Similar to 
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MAP2 results, no difference was observed between the genders (data not shown).  
However, the TLR2 -/- mice were significantly protected from myelin loss at the most 
anterior level (Figure 1 (d)) compared to the TLR2 +/+. Regarding overall comparison 
in percentage loss of myelin the TLR2 -/- mice were significantly protected by 14% 
(Figure 1 (h)). 
 
6.3 Figure 1 
 
 
	(Figure1	(a))	Comparing	MAP2	(neuronal	marker)	loss	in	saline	(n=	14)	injected	and	P3C	(n=15)	
injected	neonatal	mice,	14-hours	prior	to	HI,	from	five	different	levels	(L1-L5).	MAP2	stained	areas	
calculated	as	loss	in	%-stained	area.			
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(Figure1	(b))	Comparison	of	MAP2	neuronal	loss	in	P3C	injected	TLR2	+/+	(n=13)	and						TLR2	-/-	(n=20)	
mice,	14-hours	prior	to	HI,	from	five	different	levels	(L1-L5).	MAP2	stained	areas	calculated	as	loss	in	
%-stained	area.			
	
(Figure1	(c))	Comparison	of	MBP	loss	in	subcortical	white	matter,	in	saline	(n=	14)	and	P3C	(n=15)	
injected	neonatal	mice,	14-hours	prior	to	HI,	from	three	different	levels	(L2-L4).	MBP	stained	areas	
calculated	as	loss	in	%-stained	area.		
	
(Figure1	(d))	Comparing	MBP	loss	in	P3C	injected	TLR2	+/+	(n=13)	and	TLR2	-/-	(n=20)	mice,	prior	to	HI,	
from	three	different	levels	(L2-L4).	MBP	stained	areas	calculated	as	loss	in	%-stained	area		
	
	(Figure1	(e,f))	Total	MAP2	percentage	loss	in	mice	described	in	(a)	and	(b).		
	(Figure1	(g,h))	Total	MBP	percentage	loss	in	mice	described	in	(c)	and	(d).		
	
All	data	are	presented	as	Mean ± SEM.	The	asterisks	(*)	on	the	bars	in	(a-d)	marks	significant	
difference,	obtained	by	two-way	analysis	of	variance	(ANOVA)	analysis	followed	by	Bonferroni	post	
hoc	test.	The	numbers	on	the	bars	in	(e-h)	show	the	p	values	obtained	by	student	t-test.	
	
6.4 Suppression on brain mitochondria respiration 
To evaluate if mitochondrial function is affected following TLR2 activation we used 
high-resolution respirometry to assess mitochondrial respiration in real-time with 
various substrates for complex I activity (Figure 2(a)). The system we used has a high 
sensitivity and low signal to noise ratio. Respiratory control ratio in the P3C 
(13.53 ± 0.56, n = 13) versus the Saline (13.81 ± 0.51, n = 13, p = 0.544) control mice 
was not significant at 14h after P3C administration. However, the ADP-induced 
phosphorylating respiration (OXPHOS capacity) was suppressed significantly in the 
P3C treated mice by 23% compared to the control (p= 0.040).  OXPHOS corrected 
for leak state (Free OXPHOS capacity) was also decreased by 23.9% (Figure 2(b)). 
P3C diminished the electron transport system (ETS) capacity by 21%, although the 
difference did not reach statistical significance (p = 0.054). Free ETS capacity showed 
a 22% suppression after P3C treatment (Figure 2(c)). 
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6.5 Figure 2 
 
(Figure	2(a))	A	representative	respirogram	of	brain	mitochondria,	isolated	from	mice	injected	
intraperitoneally	with	saline	(red	line)	or	P3C	(green	line)	at	14	hours	prior	to	analysis.	L:	leak	state;	
D = ADP-induced	OXPHOS	and	U = uncoupled	respiration.		
	
(Figure	2(b))	Free	OXPHOS	capacity	(max	OXPHOS	capacity	mediated	by	complex	I	activity	and	
corrected	for	leak	respiration)	as	calculated	by	subtracting	L	from	D,	and	normalized	to	protein	
concentration.	(n = 13	per	group).		The	number	above	the	bar	indicates	p	value	obtained	by	student	t-
test.	
	
(Figure	2(c))	Free	ETS	capacity	(uncoupled	respiration	corrected	for	leak	respiration)	as	calculated	by	
subtracting	L	from	U,	and	normalized	to	protein	concentration	(n = 13	per	group).	The	data	are	
presented	as	Mean ± SEM.	The	number	above	the	bar	indicates	p	value	obtained	by	student	t-test.		
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6.6 Differences in Microglia population 
To map out the possible differences in number of microglia cells in the P3C and 
Saline injected mice, as well as differences in WT and TLR2 KO mice, we used 
Stereo Investigator 64 with Fractionator plug in software to estimate the number of 
cells. A statistically significant difference could be proven between the ipsilateral and 
contralateral hemispheres in the P3C and Saline injected mice (Figure 3(a)). 
Furthermore, a statistically significant difference could be shown between the 
ipsilateral and contralateral hemispheres in WT and TLR 2 KO mice (Figure 3 (b)). 
However, no significant differences could be proven between the P3C and Saline 
injected mice or in the WT and TLR2 KO mice.  
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(a) 
(b) 
6.7 Figure 3 
 
 
 
	(Figure	3(a))	A	representative	diagram	of	the	estimated	number	of	microglia,	cells/mm2,	in	the	
contralateral	and	ipsilateral	hemispheres	in	saline	and	P3C	injected	mice	at	five	days	after	HI	injury	at	
P9.	
	
(Figure	(3b))	A	representative	diagram	of	the	estimated	cell	population	of	microglia,	cells/mm2,	in	the	
contralateral	and	ipsilateral	hemispheres	in	wildtype	(WT)	and	TLR	2	knockout	(KO)	mice.		
	
All	data	is	presented	as	Mean ± SEM,	the	asterisks	(*)	marks	statistically	significant	difference.		
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7. DISCUSSION 
Our results suggest that systemic activation of TLR2 suppresses mitochondrial 
respiration and exacerbates HI induced brain injury. 
 
Inflammation is present whether perinatal brain injury occurs in term or pre-term 
infants. Furthermore, pre-term birth is often a result of maternal infections. There are 
many different causes of perinatal brain injury, metabolic and ischemic, such as 
hypoxia-ischemia, arterial ischemic stroke and intrauterine growth retardation, just to 
name a few. Inflammation can occur before, during and after the brain injury, and 
influences the extent of the injury.  Perinatal HI has been linked to neonatal 
encephalopathy and neurodevelopmental disorders like cerebral palsy. In addition, 
infections intensify the risk of developing brain injury 17,35.  
 
TLR2 plays a key role in initiating of an inflammatory response, when infections with 
mycoplasma and Gram-positive are present. Recent studies have shown that repeated 
injections with P3C in neonatal mice harm normal brain development 46. Another 
study of interest shows that TLR2 -/- mice are more protected to HI induced brain 
injuries 47. Our results show that TLR2 activation by single dose of P3C amplifies the 
HI induced brain injury, seen as increased neural tissue loss and demyelination.  
Bacterial endotoxins, that initiates an inflammatory response through TLR4 
activation, dramatically sensitizes the neonatal brain in rats to subsequent HI 48. 
Similar effects have been shown following TLR3 activation 20.   However, not all 
evidence point towards the same conclusion and there are also reports that show a 
protective effect of TLR2 activation prior to HI, though in adult mice 49, 50. This might 
be explained with different immune response mechanisms in the newborn compared 
to the adult, or different intervals between P3C administration and HI. The time 
interval between LPS administration and following HI insult has been shown to be 
critical 51. However, the mechanisms behind this inflammation/infection increased 
injury vulnerability is still unknown. 
 
Regarding the possible effects on microglial cell population, our results show no 
difference in the P3C or Saline injected mice. The only statistically significant 
difference is between the injured and uninjured hemisphere. Thus, the data suggest 
that it may not be the number of microglia that is responsible for increasing the 
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vulnerability. To further understand the role of microglia in P3C sensitization; 
earlier/later time points or specific phenotypes of microglia could be investigated.  
Iba-1 is today an adequate marker for Microglia visualization, but its similarity and 
possible overlap with MRF-1 (Microglia response factor) and whether it could be 
used as a Microglia marker is not determined56. Activated, or more correctly 
illustrated, reactive Microglia expresses more Iba-1 than ramified (resting) Microglia 
and this can make the cell counting procedure more difficult. The plasticity, and the 
different phases of Microglial “activation” would be interesting to investigate further.     
 
We also found that systemic activation of TLR2 suppressed mitochondrial ATP 
production through suppression of complex I mediated oxidative phosphorylation. 
The high resolution respirometry results implement an overall estimation of the 
cellular respiration, during a state of systemic TLR2 activation. To evaluate a 
complete effect of how systemic TLR2 activation affects cellular respiration and ATP 
production, a more detailed analysis involving the rest of the complexes and enzymes 
is needed. Accurate evidence regarding local and systemic inflammation effects on 
brain mitochondria is narrow, but harmful impacts has been reported in some studies 
52, 53. Further investigation is definitely needed for more accurate statements. 
However, there are some potential hypotheses that have been examined, for example 
that suppressed respiration leads to necrosis pathways initiated by cumulative effects 
of ATP depletion, and the possible effects of glutamate excitotoxity 54.  
 
In conclusion, our results show, for the first time, that systemic TLR2 activation 
exacerbates neonatal HI brain injury. Inflammation-induced suppression of cellular 
respiration may play a role and increase the vulnerability to HI injury. Therefore, 
targeting mitochondrial dysfunction in inflammation-related neonatal brain injury 
may be a novel therapeutic strategy.   
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8. POPULÄRVETENSKAPLIG TEXT PÅ SVENSKA 
 
Introduktion 
Inflammation är kroppens egna sätt att reagera på något som kan potentiellt vara 
skadligt för kroppen. Inflammation kan ses som en inbyggd försvarsmekanism mot 
yttre hot. Vad som kan orsaka inflammation är exempelvis fysiska skador på kroppen, 
tillstånd som leder till syrebrist i kroppens olika organ och infektioner med bakterier 
och virus mm. Inflammation är inte alltid bra, det kan även skada kroppen. Exempel 
på detta är vissa sjukdomar där kroppens försvarsmekanismer angriper kroppens egna 
vävnader och organ (autoimmunitet). Detta ses till exempel i sjukdomar som Multipel 
Skleros (MS), Diabetes typ 1 och inflammatoriska tarmsjukdomar. Nyfödda barn som 
utsätts för syrebrist i hjärnan och/eller infektioner under graviditeten, kan få allvarliga 
skador och bestående men i form av Cerebral Pares (CP) eller svåra 
inlärningsproblem. I värsta fall kan även död inträffa. Inflammationsprocesserna kan 
vara väldigt komplexa och i sistnämnda fallet vet man inte exakt hur detta går till.       
 
För att förstå sig på inflammation och dess konsekvenser måste man förstå sig på 
mekanismerna bakom detta. Toll-Like Receptorer (TLR) är receptorer som finns på 
många kroppens vita blodkroppar och de är involverade i igenkänning av flertalet 
bakterier, virus och svampar. När en TLR binder in exempelvis på en bakterie så 
börjar inflammationsprocessen vars uppgift är att avlägsna i detta fall bakterien.  Toll-
like receptor 2 (TLR2), som är en grupp av Toll-Like receptorer, känner igen 
bakteriella strukturer som förekommer till exempel i mycoplasma och Gram positiva 
bakterier. Dessa två är även en av de vanligaste bakteriella infektionerna hos gravida.  
 
Syfte med studien: I denna studie tittar vi på effekten av TLR2 aktivering 
tillsammans med syrebrist i hjärnan. Vi kollar efter parametrar som: storlek på 
hjärnskada och effekten på de utsatta cellers energiproduktion. 
 
Metoder 
Genom att använda möss som saknar TLR2 och jämföra med vanliga möss kan vi 
svara på frågorna vi undrar över. För att orsaka en hjärnskada så kommer vi att strypa 
blodflödet till hjärnan på mössen och sedan lägga dem i en syrefattig kammare. Innan 
detta kommer vi att stimulera TLR2 med artificiella substanser. Därefter analyseras 
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hjärnorna med att färga in hjärnvävnad med olika färger och sedan analysera dessa i 
mikroskop. Slutligen analyseras cellernas energiproduktion med högupplöst 
respirometri (metod för att analysera olika delar i energiproduktionen).  
 
 
Resultat  
Vi kunde påvisa att storleken på hjärnskadan hade en koppling till om mössen 
saknade TLR2. De möss som saknade TLR2 hade mindre storlek på hjärnskadan det 
vill säga mindre hjärnceller (nervceller) i den analyserade hjärnan. Även negativa 
effekter på elektrontransportkedjan (en del av cellens energiproduktion) sågs i de 
möss som hade TLR2. Detta betyder alltså att TLR2 aktivering innan en period av 
syrebrist gör hjärnan mera sårbar för skada, och utfallet efter syrebristen blir 
signifikant värre.  Detta summerat talar för att infektion och eller inflammation bidrar 
till förvärring av syrebrist orsakade hjärnskador.  
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11. APPENDIX 1 
 
DNA Extraction Using Sigma XNAT kit 
Do this in Western Lab 
Use filter pipette tips 
1. For each sample pipette 50 µl of Extraction Solution into microcentrifuge 
tube, add 12.5 µl of Tissue Preparation Solution _ pipette up and down 
several times to mix. (4 part ES, 1 part TP) 
2. Place ear/tail biopsy into the solution _ mix thoroughly via vortexing 
3. Incubate in RT for 10-20 minutes. 
4. Incubate at 96⁰C for 3 minutes. (Tissue will not be digested!)  
5. Add 50 µl of Neutralizing Solution B and mix by vortexing 
6. Store at 4⁰C or use immediately. For long-term remove the tissue and freeze 
the rest. 
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12. APPENDIX 2 
MAP-2 Immunohistochemistry 
 
Primary antibody: monoclocal anti-MAP2, clone HM-2 (Sigma) 
Secondary antibody: biotinylated Horse anti-mouse (Vector) 
 
 
Protocol 
 
1. Melt paraffin at 65ºC for 30min 
2. Deparaffinise: Xylene 10min, 100% 5min, 95% 5min, 70% 5min 
3. 3x5min washes in PBS/tween20 (Heat citrate buffer for next step) 
4. Boil gently section in citrate buffer (pH6) for 10 min 
5. Allow to cool for 20min 
6. 3x5min washes in PBS/tween20 
7. Block sections in H2O2 (3% in PBS) for 10min 
8. 3x5min washes in PBS/tween20 
9. Block in 3% horse serum/PBS for 30min 
10. Incubate in primary antibody (3% horse serum/PBS, 1:2000) overnight in 
fridge 
11. 3x5min washes in PBS/tween20 
12. Incubate in seconday antibody (PBS, 1:250) for 1h 
13. 3x5min washes in PBS/tween20 
14. Incubate in ABC complex for at least 30min 
15. 3x5min washes in PBS 
16. Develop with DAB kit (Vector) for about 5min 
17. Dehydrate and mount sections 
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13. APPENDIX 3 
Protocol for Stereo Investigator 64bit 
Calibrate the lens using the Calibration Grid Silde (250 µm and 25 µm) 
Fractionator 
1. Find your desired tissue section using the Microscope, 1.25x zoom. 
2. Choose the reference point in the middle of the section. 
3. To draw contours, use the Freehand option.  
4. If you want to move around, press the Joy Track button on the toolbar, 
and then use the Joystick. 
5. To end the drawings, use the Close Contour button on the toolbar. 
6. Choose Fractionator from the Probes menu. 
7. Put in your desired Grid size (for example 1000 µm x 1000 µm) 
8. Use the same Grid size during all your probe runs. 
9. Zoom in to 20x, or depending on your grid size. For counting Microglia 
20x works fine.    
10. Use a marker from the toolbar to the left.  
11.   Count all the cells from the box. If a cell crosses the green line then you 
should count it. If it crosses the red line then do not. And if it crosses both 
then leave uncounted. Use Ctrl +Z to undo.  
12. To get to the next counting frame press F2. 
13.  Go through all the counting frames until a message appears that says the 
run is complete. 
14. To show the results press the Display Probe run list button on the toolbar. 
 
